Progressive Elaboration Framework of Mortality in Treated and Controlled Hypertension: A Pooled Analysis of Contributing Factors to Silent or Uncontrollable Fatal Syndromes

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This pooled analysis investigates death outcomes in patients with pharmacologically treated and blood pressure-controlled hypertension. Despite documented BP control, some patients still suffer fatal cardiovascular, cerebrovascular, renal, or unexplained syndromes. This study aims to synthesize available evidence across study types to identify treatment pitfalls, contributing syndromes, and non-BP factors associated with these fatal outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: Newborn
Maximum Age: 130
Healthy Volunteers: f
View:

• Human studies (RCTs, cohort, case-control, registry studies, etc.) declare participants with treated and controlled hypertension manage (regardless of drug class, duration, or comorbidity) reported mortality outcomes: all-vascular death, cardiovascular death, sudden death, etc.

• Studies in any setting (outpatient, inpatient, long-term follow-up)

• Articles in English

• Full-text available

Locations
Other Locations
Thailand
Owned study
RECRUITING
Bangkok
Contact Information
Primary
Nathaphong Dejthida, MD
bnnatto@gmail.com
+66819220662
Backup
Nathaphong Dejthida, MD
bnnatto@gmail.com
Time Frame
Start Date: 2025-09-18
Estimated Completion Date: 2026-04-14
Participants
Target number of participants: 1000000
Related Therapeutic Areas
Sponsors
Leads: DejthidaNathaphong

This content was sourced from clinicaltrials.gov